GMP ORPHAN DRUGS FOR ORPHAN DISEASES
LIVE

Serial Number

79134010

Owner

GMP-ORPHAN

Attorney

Heather Smith-Carra

Filing Date

May 14, 2013

Add to watchlist:

No watchlists yet
View on USPTO

GMP ORPHAN DRUGS FOR ORPHAN DISEASES Trademark

Serial Number: 79134010 • Registration: 4541221

GMP ORPHAN DRUGS FOR ORPHAN DISEASES is a trademark filed by GMP-ORPHAN on May 14, 2013. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

GMP-ORPHAN

7 avenue Pasteur Wagner

Entity Type: 99

ORPHALAN (10 trademarks)

226 boulevard Voltaire

Entity Type: 33

Trademark Details

Filing Date

May 14, 2013

Registration Date

June 3, 2014

Published for Opposition

March 18, 2014

Cancellation Date

March 6, 2026

Goods & Services

Pharmaceutical and veterinary products for the treatment of orphan diseases; medication for the treatment of orphan diseases; pharmaceutical and veterinary products for pediatric use for the treatment of orphan diseases; medication for pediatric use for the treatment of orphan diseases; chemical preparations for medical or pharmaceutical use in the treatment of childhood diseases; pharmaceutical and veterinary products and medicines for the treatment of orphan diseases, particularly spinal muscular atrophy, sickle-cell anemia, progressive nuclear palsy, amyotrophic lateral sclerosis (ALS), cystic fibrosis, Duchenne muscular dystrophy, macrophagic myofasciitis, lysosomal storage disease, leukodystrophy; pharmaceutical and veterinary products and medicines for the treatment of hyperammonemia of all kinds

Evaluations, assessments and research in the fields of science; research and development services in the field of medicine; research and development of new products for others, namely, medical diagnosis apparatus; research and development in the field of biotechnology; scientific research for medical purposes; scientific laboratory services in the medical field; all the aforesaid services in connection with the treatment of childhood and orphan diseases, particularly spinal muscular atrophy, sickle-cell anemia, progressive nuclear palsy, amyotrophic lateral sclerosis (ALS), cystic fibrosis, Duchenne muscular dystrophy, macrophagic myofasciitis, lysosomal storage disease, leukodystrophy

Medical services; medical and sanitary care, namely, telemedecine services including remote diagnosis or medical follow-up; medical testing for the diagnosis and treatment of persons; providing medical advice on health matters in the field of medication administration; providing medical advisory services relating to medical apparatus and instruments; medical diagnosis services of orphan diseases; providing medical information, all the aforesaid services in connection with the treatment of childhood and orphan diseases, particularly spinal muscular atrophy, sickle-cell anemia, progressive nuclear palsy, amyotrophic lateral sclerosis (ALS), cystic fibrosis, Duchenne muscular dystrophy, macrophagic myofasciitis, lysosomal storage disease, leukodystrophy

[ Medical, surgical and veterinary apparatus and instruments, for diagnosis and treatment, particularly in connection with orphan diseases; medical devices containing chemical products for diagnostic use of orphan diseases; medical diagnosis apparatus and instruments to diagnose orphan diseases; automatic testing apparatus to diagnose orphan diseases, for medical use, also in the form of kits; medical apparatus and instruments in the form of kits for detecting the presence of analytes in biological fluids, other fluids and other structures; immunochemical testing apparatus for medical use; blood testing apparatus; radiological apparatus for medical use; resuscitation apparatus; medical imaging apparatus incorporating medical imaging software; needles for medical use; gloves for medical use; syringes for medical use; inhalers for medical purposes; injectors for medical use; X-ray photographs for medical use; radiology screens for medical use; receptacles for applying medicines; containers especially made for medical waste; probes for medical use; stethoscopes; heart pacemakers; thermometers for medical use; cases fitted for medical instruments for use by surgeons or doctors ]

Filing History

CANCELLED SECTION 71
Mar 6, 2026 C71T
INTERNATIONAL REGISTRATION RENEWED
Jun 9, 2023 RNWL
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Jun 3, 2023 REM4
PARTIAL INVALIDATION PROCESSED BY THE IB
Dec 5, 2021 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Oct 27, 2021 INPS
INVALIDATION PROCESSED
Oct 27, 2021 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 6, 2021 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Feb 6, 2021 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Feb 6, 2021 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 1, 2021 APRE
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 29, 2021 ADCH
TEAS SECTION 71 RECEIVED
Dec 3, 2020 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 3, 2019 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Feb 7, 2019 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 8, 2018 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Mar 3, 2016 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 21, 2014 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 21, 2014 FICS
FINAL DISPOSITION PROCESSED
Oct 21, 2014 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 3, 2014 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 3, 2014 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 18, 2014 NPUB
PUBLISHED FOR OPPOSITION
Mar 18, 2014 PUBO
NOTIFICATION PROCESSED BY IB
Mar 14, 2014 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 26, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 26, 2014 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 26, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 7, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 5, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 5, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 5, 2014 CRFA
ASSIGNED TO LIE
Jan 30, 2014 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 22, 2014 TROA
REFUSAL PROCESSED BY IB
Sep 30, 2013 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 11, 2013 RFCS
REFUSAL PROCESSED BY MPU
Sep 11, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 11, 2013 RFCR
NON-FINAL ACTION WRITTEN
Sep 10, 2013 CNRT
ASSIGNED TO EXAMINER
Sep 3, 2013 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 16, 2013 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 12, 2013 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 8, 2013 REPR